Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer

Author： Lee Sung-Hyung Mizutani Noriko Mizutani Masato Luo Yunping Zhou He Kaplan Charles Kim Sung-Woo Xiang Rong Reisfeld Ralph

Publisher： Springer Publishing Company

ISSN： 0340-7004

Source： Cancer Immunology, Immunotherapy, Vol.55, Iss.12, 2006-12, pp. : 1565-1574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic Significance of Carbonic Anhydrase IX (CA-IX), Endoglin (CD105) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in Breast Cancer Patients

By Beketic-Oreskovic Lidija

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 593-603

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer

By Nikiteas Nikolaos I. Tzanakis Nikolaos Theodoropoulos George Atsaves Vassilios Christoni Zoi Karakitsos Petros Lazaris Andreas C. Papachristodoulou Antonis Klonaris Christos Gazouli Maria

Gastric Cancer, Vol. 10, Iss. 1, 2007-02 ,pp. : 12-17

Springer Publishing Company

Access to resources Recommend Favorite

Novel chemotactic-antigen DNA vaccine against cancer

By Zhang Shuren Zhang Youhui

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 299-303

Future Medicine

Access to resources Recommend Favorite

Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status

By Bock Annika

Tumor Biology, Vol. 32, Iss. 3, 2011-06 ,pp. : 589-596

Springer Publishing Company

Access to resources Recommend Favorite

Endoglin (CD 105) is expressed on endothelial cells in the primary central nervous system lymphomas and correlates with survival

By Sugita Yasuo Takase Yukari Mori Daisuke Tokunaga Osamu Nakashima Akihiko Shigemori Minoru

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 249-256

Springer Publishing Company

Access to resources Recommend Favorite